상세 보기

Patient-reported outcomes of palbociclib plus exemestane with GnRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer from the YoungPearl phase II trial (KCSG-BR 15-10, NCT02592746)

Lee, S.;
Park, Y. H.;
Im, S-A.;
Jung, K. H.;
Park, I. H.;
외 8명

제목: Patient-reported outcomes of palbociclib plus exemestane with GnRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer from the YoungPearl phase II trial (KCSG-BR 15-10, NCT02592746)

저자: Lee, S.; Park, Y. H.; Im, S-A.; Jung, K. H.; Park, I. H.; Kang, S. Y.; Kim, J. H.; Kim, G. M.; Lee, K-E.; Ahn, H.; Lee, M. H.; Kim, H. J.; Koh, S.

DOI: 10.1093/annonc/mdz394.013

발행일: 2019-09-29

학회명: 44th Congress of the European-Society-for-Medical-Oncology (ESMO)

개최지: Barcelona, SPAIN

개최국가: 영국

학회 개최일: 2019-09-27 ~ 2019-10-01

언어: ENG